Stability, variability, and treatment implications of the blood eosinophil count in Korean patients with chronic obstructive pulmonary disease.
作者信息
Lee Hyun Woo
机构信息
Division of Respiratory and Critical Care, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
出版信息
Korean J Intern Med. 2025 Jan;40(1):5-6. doi: 10.3904/kjim.2024.386. Epub 2025 Jan 1.
Abstract
摘要
相似文献
1
Stability, variability, and treatment implications of the blood eosinophil count in Korean patients with chronic obstructive pulmonary disease.韩国慢性阻塞性肺疾病患者血液嗜酸性粒细胞计数的稳定性、变异性及治疗意义
Korean J Intern Med. 2025 Jan;40(1):5-6. doi: 10.3904/kjim.2024.386. Epub 2025 Jan 1.
2
Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease.稳定期血嗜酸性粒细胞计数的变异性预测慢性阻塞性肺疾病加重风险。
Int J Chron Obstruct Pulmon Dis. 2023 Jun 12;18:1145-1153. doi: 10.2147/COPD.S401357. eCollection 2023.
3
Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma.慢性阻塞性肺疾病和严重哮喘中的血嗜酸性粒细胞计数变异性。
Allergol Int. 2023 Jul;72(3):402-410. doi: 10.1016/j.alit.2022.11.012. Epub 2022 Dec 29.
4
[Study of the role of blood eosinophil count in patients with severe acute exacerbation of chronic obstructive pulmonary disease hospitalized in a Tunisian Center].[突尼斯某中心收治的慢性阻塞性肺疾病严重急性加重患者血液嗜酸性粒细胞计数作用的研究]
Pan Afr Med J. 2019 Nov 8;34:138. doi: 10.11604/pamj.2019.34.138.17392. eCollection 2019.
5
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的血嗜酸性粒细胞计数阈值与加重。
J Allergy Clin Immunol. 2018 Jun;141(6):2037-2047.e10. doi: 10.1016/j.jaci.2018.04.010. Epub 2018 Apr 28.
6
Blood Eosinophil Count Stability and Clinical Outcomes in Patients With Chronic Obstructive Pulmonary Disease in a High Endemic Area of Parasitic Infection: A Prospective Study.寄生虫感染高流行地区慢性阻塞性肺疾病患者的血嗜酸性粒细胞计数稳定性及临床结局：一项前瞻性研究
Chronic Obstr Pulm Dis. 2024 Jul 25;11(4):350-358. doi: 10.15326/jcopdf.2023.0492.
7
Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.非哮喘-慢性阻塞性肺疾病（COPD）重叠综合征患者血液嗜酸性粒细胞计数的临床意义。
Int J Chron Obstruct Pulmon Dis. 2017 Aug 17;12:2455-2464. doi: 10.2147/COPD.S129321. eCollection 2017.
8
Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.血嗜酸性粒细胞计数与慢性阻塞性肺疾病患者肺炎风险：一项基于患者的荟萃分析。
Lancet Respir Med. 2016 Sep;4(9):731-741. doi: 10.1016/S2213-2600(16)30148-5. Epub 2016 Jul 23.
9
The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease.血嗜酸性粒细胞百分比与慢性阻塞性肺疾病急性加重期细菌感染的关系。
Int J Chron Obstruct Pulmon Dis. 2019 May 6;14:953-959. doi: 10.2147/COPD.S197361. eCollection 2019.
10
Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的血嗜酸性粒细胞计数与临床转归。
Respir Res. 2018 Jul 13;19(1):134. doi: 10.1186/s12931-018-0840-x.
本文引用的文献
1
Blood eosinophil count and treatment patterns of chronic obstructive pulmonary disease patients in South Korea using real-world data.利用真实世界数据分析韩国慢性阻塞性肺疾病患者的血液嗜酸性粒细胞计数及治疗模式
Korean J Intern Med. 2025 Jan;40(1):78-91. doi: 10.3904/kjim.2024.034. Epub 2025 Jan 1.
2
Risk factors of acute exacerbation and disease progression in young patients with COPD.慢性阻塞性肺疾病（COPD）年轻患者急性加重和疾病进展的危险因素
BMJ Open Respir Res. 2024 Jul 17;11(1):e001740. doi: 10.1136/bmjresp-2023-001740.
3
Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction.支气管扩张和气流阻塞患者长期吸入联合治疗的临床结局。
BMC Pulm Med. 2024 Jan 23;24(1):49. doi: 10.1186/s12890-024-02867-4.
4
Validation of the Rome proposal for severity of acute exacerbation of chronic obstructive pulmonary disease.验证罗马提出的慢性阻塞性肺疾病急性加重严重程度的提案。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231172917. doi: 10.1177/17534666231172917.
5
Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects.慢性阻塞性肺疾病中的血液嗜酸性粒细胞计数：吸入性糖皮质激素疗效的生物标志物
Tuberc Respir Dis (Seoul). 2020 Jul;83(3):185-194. doi: 10.4046/trd.2020.0026. Epub 2020 Apr 29.
6
Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study.基于人群的研究：血嗜酸性粒细胞计数及其变异性与 COPD 加重的风险。
Arch Bronconeumol (Engl Ed). 2021 Jan;57(1):13-20. doi: 10.1016/j.arbres.2019.12.015. Epub 2020 Feb 13.
7
Inhaled corticosteroids in COPD: friend or foe?COPD 患者的吸入性皮质类固醇：是敌是友？
Eur Respir J. 2018 Dec 13;52(6). doi: 10.1183/13993003.01219-2018. Print 2018 Dec.
8
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的血嗜酸性粒细胞计数阈值与加重。
J Allergy Clin Immunol. 2018 Jun;141(6):2037-2047.e10. doi: 10.1016/j.jaci.2018.04.010. Epub 2018 Apr 28.
9
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD.持续性血嗜酸性粒细胞增多症的患病率：与 COPD 患者结局的关系。
Eur Respir J. 2017 Nov 22;50(5). doi: 10.1183/13993003.01162-2017. Print 2017 Nov.
10
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.痰和血嗜酸性粒细胞浓度与 COPD 严重程度的临床指标的关联：SPIROMICS 队列分析。
Lancet Respir Med. 2017 Dec;5(12):956-967. doi: 10.1016/S2213-2600(17)30432-0. Epub 2017 Nov 13.
Zotero 插件